{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:52:51Z","timestamp":1782744771832,"version":"3.54.5"},"reference-count":45,"publisher":"Pharmaceutical Society of Japan","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,9,23]]},"DOI":"10.1248\/bpb.b25-00490","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T22:06:28Z","timestamp":1758578788000},"page":"1428-1434","source":"Crossref","is-referenced-by-count":1,"title":["Effect of RANTES on Vascular Contractile and Relaxant Responses in Rat Carotid Arteries"],"prefix":"10.1248","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9177-8384","authenticated-orcid":false,"given":"Takayuki","family":"Matsumoto","sequence":"first","affiliation":[{"name":"Second Department of Pharmacology, School of Pharmaceutical Sciences, Kyushu University of Medical Science, Nobeoka, Miyazaki 882\u20138508, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Nagano","sequence":"additional","affiliation":[{"name":"First Department of Pharmacology, School of Pharmaceutical Sciences, Kyushu University of Medical Science, Nobeoka, Miyazaki 882\u20138508, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Tanaka-Totoribe","sequence":"additional","affiliation":[{"name":"First Department of Pharmacology, School of Pharmaceutical Sciences, Kyushu University of Medical Science, Nobeoka, Miyazaki 882\u20138508, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Touyz RM, Alves-Lopes R, Rios FJ, Camargo LL, Anagnostopoulou A, Arner A, Montezano AC. Vascular smooth muscle contraction in hypertension. <i>Cardiovasc. Res.<\/i>, <b>114<\/b>, 529\u2013539 (2018).","DOI":"10.1093\/cvr\/cvy023"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Matsumoto T, Goulopoulou S, Taguchi K, Tostes RC, Kobayashi T. Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes. <i>Br. J. Pharmacol.<\/i>, <b>172<\/b>, 3980\u20134001 (2015).","DOI":"10.1111\/bph.13205"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Vanhoutte PM, Shimokawa H, Feletou M, Tang EH. Endothelial dysfunction and vascular disease\u2014a 30th anniversary update. <i>Acta Physiol. (Oxf.)<\/i>, <b>219<\/b>, 22\u201396 (2017).","DOI":"10.1111\/apha.12646"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Goulopoulou S, Webb RC. Symphony of vascular contraction: how smooth muscle cells lose harmony to signal increased vascular resistance in hypertension. <i>Hypertension<\/i>, <b>63<\/b>, e33\u2013e39 (2014).","DOI":"10.1161\/HYPERTENSIONAHA.113.02444"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Matsumoto T, Nagano T, Yokota A, Nakamura E, Kuwabara M, Yamamoto R, Tanaka-Totoribe N. Differential suppressive effects of Rho kinase inhibitor fasudil on serotonin- and noradrenaline-induced contractions of human internal thoracic arteries and saphenous veins. <i>Biol. Pharm. Bull.<\/i>, <b>47<\/b>, 1657\u20131661 (2024).","DOI":"10.1248\/bpb.b24-00502"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Obara K, Yoshioka K, De Dios Regadera M, Matsuyama Y, Yashiro A, Miyokawa M, Iura R, Tanaka Y. Phenylephrine-induced contraction in guinea pig thoracic aorta is triggered by stimulation of <i>\u03b1<\/i><sub>1L<\/sub>-adrenoceptors functionally coupled with store-operated Ca<sup>2+<\/sup> channels and voltage-dependent Ca<sup>2+<\/sup> channels. <i>Biol. Pharm. Bull.<\/i>, <b>46<\/b>, 309\u2013319 (2023).","DOI":"10.1248\/bpb.b22-00754"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Mori A, Namekawa R, Sakamoto K, Ishii K, Nakahara T. Involvement of Gap junctions in acetylcholine-induced endothelium-derived hyperpolarization-type dilation of retinal arterioles in rats. <i>Biol. Pharm. Bull.<\/i>, <b>44<\/b>, 1860\u20131865 (2021).","DOI":"10.1248\/bpb.b21-00547"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Toto\u0144-\u017bura\u0144ska J, Mikolajczyk TP, Saju B, Guzik TJ. Vascular remodelling in cardiovascular diseases: hypertension, oxidation, and inflammation. <i>Clin. Sci.<\/i>, <b>138<\/b>, 817\u2013850 (2024).","DOI":"10.1042\/CS20220797"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Mikolajczyk TP, Szczepaniak P, Vidler F, Maffia P, Graham GJ, Guzik TJ. Role of inflammatory chemokines in hypertension. <i>Pharmacol. Ther.<\/i>, <b>223<\/b>, 107799 (2021).","DOI":"10.1016\/j.pharmthera.2020.107799"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Taguchi K, Furukawa T, Matsumoto T, Kobayashi T. Esaxerenone improves vascular endothelial dysfunction by reducing serum and glucocorticoid-regulated kinase 1 activity and enhancing the Akt pathway in type 2 diabetic mice. <i>Biol. Pharm. Bull.<\/i>, <b>48<\/b>, 422\u2013431 (2025).","DOI":"10.1248\/bpb.b25-00009"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Matsumoto T, Osada T, Taguchi K, Kobayashi T. Endothelial Dysfunction in Superior Mesenteric Arteries Isolated from Adenine-Induced Renal Failure in Model Rats. <i>Biol. Pharm. Bull.<\/i>, <b>46<\/b>, 1156\u20131160 (2023).","DOI":"10.1248\/bpb.b23-00234"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Matsumoto T, Kudo M, Taguchi K, Kobayashi T. Effect of nonsteroidal mineralocorticoid receptor blocker esaxerenone on vasoreactivity to an endothelial stimulator in superior mesenteric arteries of type 2 diabetic Goto-Kakizaki Rat. <i>Biol. Pharm. Bull.<\/i>, <b>45<\/b>, 1825\u20131831 (2022).","DOI":"10.1248\/bpb.b22-00616"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Nakagawa K, Kobayashi F, Kamei Y, Tawa M, Ohkita M. Acute kynurenine exposure of rat thoracic aorta induces vascular dysfunction <i>via<\/i> superoxide anion production. <i>Biol. Pharm. Bull.<\/i>, <b>45<\/b>, 522\u2013527 (2022).","DOI":"10.1248\/bpb.b21-01079"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Zeng Z, Lan T, Wei Y, Wei X. CCL5\/CCR5 axis in human diseases and related treatments. <i>Genes Dis.<\/i>, <b>9<\/b>, 12\u201327 (2022).","DOI":"10.1016\/j.gendis.2021.08.004"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Bakogiannis C, Sachse M, Stamatelopoulos K, Stellos K. Platelet-derived chemokines in inflammation and atherosclerosis. <i>Cytokine<\/i>, <b>122<\/b>, 154157 (2019).","DOI":"10.1016\/j.cyto.2017.09.013"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Chen Y, Lv G, Du X, Yang F, Zhao Z. Fentanyl promoted the growth of placenta trophoblast cells through regulating the METTL14 mediated CCL5 levels. <i>Biol. Pharm. Bull.<\/i>, <b>46<\/b>, 1797\u20131804 (2023).","DOI":"10.1248\/bpb.b23-00531"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Levy JA. The unexpected pleiotropic activities of RANTES. <i>J. Immunol.<\/i>, <b>182<\/b>, 3945\u20133946 (2009).","DOI":"10.4049\/jimmunol.0990015"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Appay V, Rowland-Jones SL. RANTES: a versatile and controversial chemokine. <i>Trends Immunol.<\/i>, <b>22<\/b>, 83\u201387 (2001).","DOI":"10.1016\/S1471-4906(00)01812-3"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Liu H, Ning H, Men H, Hou R, Fu M, Zhang H, Liu J. Regulation of CCL5 expression in smooth muscle cells following arterial injury. <i>PLoS One<\/i>, <b>7<\/b>, e30873 (2012).","DOI":"10.1371\/journal.pone.0030873"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Veillard NR, Kwak B, Pelli G, Mulhaupt F, James RW, Proudfoot AE, Mach F. Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. <i>Circ. Res.<\/i>, <b>94<\/b>, 253\u2013261 (2004).","DOI":"10.1161\/01.RES.0000109793.17591.4E"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Rudemiller NP, Crowley SD. The role of chemokines in hypertension and consequent target organ damage. <i>Pharmacol. Res.<\/i>, <b>119<\/b>, 404\u2013411 (2017).","DOI":"10.1016\/j.phrs.2017.02.026"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Lin CS, Hsieh PS, Hwang LL, Lee YH, Tsai SH, Tu YC, Hung YW, Liu CC, Chuang YP, Liao MT, Chien S, Tsai MC. The CCL5\/CCR5 axis promotes vascular smooth muscle cell proliferation and atherogenic phenotype switching. <i>Cell. Physiol. Biochem.<\/i>, <b>47<\/b>, 707\u2013720 (2018).","DOI":"10.1159\/000490024"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Singh S, Bruder-Nascimento A, Belin de Chantemele EJ, Bruder-Nascimento T. CCR5 antagonist treatment inhibits vascular injury by regulating NADPH oxidase 1. <i>Biochem. Pharmacol.<\/i>, <b>195<\/b>, 114859 (2022).","DOI":"10.1016\/j.bcp.2021.114859"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Krensky AM, Ahn YT. Mechanisms of disease: regulation of RANTES (CCL5) in renal disease. <i>Nat. Clin. Pract. Nephrol.<\/i>, <b>3<\/b>, 164\u2013170 (2007).","DOI":"10.1038\/ncpneph0418"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Czepluch FS, Meier J, Binder C, Hasenfuss G, Sch\u00e4fer K. CCL5 deficiency reduces neointima formation following arterial injury and thrombosis in apolipoprotein E-deficient mice. <i>Thromb. Res.<\/i>, <b>144<\/b>, 136\u2013143 (2016).","DOI":"10.1016\/j.thromres.2016.06.013"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Costa RM, Cerqueira DM, Bruder-Nascimento A, Alves JV, Awata WMC, Singh S, Kufner A, Prado DS, Johny E, Cifuentes-Pagano E, Hawse WF, Dutta P, Pagano PJ, Ho J, Bruder-Nascimento T. Role of the CCL5 and its receptor, CCR5, in the genesis of aldosterone-induced hypertension, vascular dysfunction, and end-organ damage. <i>Hypertension<\/i>, <b>81<\/b>, 776\u2013786 (2024).","DOI":"10.1161\/HYPERTENSIONAHA.123.21888"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Mikolajczyk TP, Nosalski R, Szczepaniak P, Budzyn K, Osmenda G, Skiba D, Sagan A, Wu J, Vinh A, Marvar PJ, Guzik B, Podolec J, Drummond G, Lob HE, Harrison DG, Guzik TJ. Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension. <i>FASEB J.<\/i>, <b>30<\/b>, 1987\u20131999 (2016).","DOI":"10.1096\/fj.201500088R"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Matsumoto T, Takayanagi K, Kojima M, Taguchi K, Kobayashi T. Mechanisms underlying suppression of noradrenaline-induced contraction by prolonged treatment with advanced glycation end-products in organ-cultured rat carotid artery. <i>Pflugers Arch.<\/i>, <b>472<\/b>, 355\u2013366 (2020).","DOI":"10.1007\/s00424-020-02349-6"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Ando M, Matsumoto T, Taguchi K, Kobayashi T. Poly (I: C) impairs NO donor-induced relaxation by overexposure to NO <i>via<\/i> the NF-kappa B\/iNOS pathway in rat superior mesenteric arteries. <i>Free Radic. Biol. Med.<\/i>, <b>112<\/b>, 553\u2013566 (2017).","DOI":"10.1016\/j.freeradbiomed.2017.08.027"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Watanabe S, Matsumoto T, Oda M, Yamada K, Takagi J, Taguchi K, Kobayashi T. Insulin augments serotonin-induced contraction <i>via<\/i> activation of the IR\/PI3K\/PDK1 pathway in the rat carotid artery. <i>Pflugers Arch<\/i>, <b>468<\/b>, 667\u2013677 (2016).","DOI":"10.1007\/s00424-015-1759-4"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Ozaki H, Karaki H. Organ culture as a useful method for studying the biology of blood vessels and other smooth muscle tissues. <i>Jpn. J. Pharmacol.<\/i>, <b>89<\/b>, 93\u2013100 (2002).","DOI":"10.1254\/jjp.89.93"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Mukohda M, Morita T, Okada M, Hara Y, Yamawaki H. Long-term methylglyoxal treatment impairs smooth muscle contractility in organ-cultured rat mesenteric artery. <i>Pharmacol. Res.<\/i>, <b>65<\/b>, 91\u201399 (2012).","DOI":"10.1016\/j.phrs.2011.08.005"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Matsumoto T, Kudo M, Osada T, Taguchi K, Kobayashi T. Methylglyoxal impairs ATP- and UTP-induced relaxation in the rat carotid arteries. <i>Eur. J. Pharmacol.<\/i>, <b>933<\/b>, 175259 (2022).","DOI":"10.1016\/j.ejphar.2022.175259"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Jackson WF. Potassium channels in regulation of vascular smooth muscle contraction and growth. <i>Adv. Pharmacol.<\/i>, <b>78<\/b>, 89\u2013144 (2017).","DOI":"10.1016\/bs.apha.2016.07.001"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Krishnamoorthy-Natarajan G, Koide M. BK channels in the vascular system. <i>Int. Rev. Neurobiol.<\/i>, <b>128<\/b>, 401\u2013438 (2016).","DOI":"10.1016\/bs.irn.2016.03.017"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Akagawa M, Mori A, Sakamoto K, Nakahara T. Methylglyoxal impairs <i>\u03b2<\/i><sub>2<\/sub>-adrenoceptor-mediated vasodilatory mechanisms in rat retinal arterioles. <i>Biol. Pharm. Bull.<\/i>, <b>41<\/b>, 272\u2013276 (2018).","DOI":"10.1248\/bpb.b17-00861"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Incalza MA, D\u2019Oria R, Natalicchio A, Perrini S, Laviola L, Giorgino F. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. <i>Vascul. Pharmacol.<\/i>, <b>100<\/b>, 1\u201319 (2018).","DOI":"10.1016\/j.vph.2017.05.005"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Matsumoto T, Noguchi E, Kobayashi T, Kamata K. Mechanisms underlying the chronic pioglitazone treatment-induced improvement in the impaired endothelium-dependent relaxation seen in aortas from diabetic rats. <i>Free Radic. Biol. Med.<\/i>, <b>42<\/b>, 993\u20131007 (2007).","DOI":"10.1016\/j.freeradbiomed.2006.12.028"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Braunersreuther V, Pellieux C, Pelli G, Burger F, Steffens S, Montessuit C, Weber C, Proudfoot A, Mach F, Arnaud C. Chemokine CCL5\/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice. <i>J. Mol. Cell. Cardiol.<\/i>, <b>48<\/b>, 789\u2013798 (2010).","DOI":"10.1016\/j.yjmcc.2009.07.029"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Matsumoto T, Noguchi E, Ishida K, Kobayashi T, Yamada N, Kamata K. Metformin normalizes endothelial function by suppressing vasoconstrictor prostanoids in mesenteric arteries from OLETF rats, a model of type 2 diabetes. <i>Am. J. Physiol. Heart Circ. Physiol.<\/i>, <b>295<\/b>, H1165\u2013H1176 (2008).","DOI":"10.1152\/ajpheart.00486.2008"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Matsumoto T, Nakayama N, Ishida K, Kobayashi T, Kamata K. Eicosapentaenoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium-derived factors in mesenteric arteries from rats at chronic stage of type 2 diabetes. <i>J. Pharmacol. Exp. Ther.<\/i>, <b>329<\/b>, 324\u2013334 (2009).","DOI":"10.1124\/jpet.108.148718"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Hernanz R, Briones AM, Salaices M, Alonso MJ. New roles for old pathways? A circuitous relationship between reactive oxygen species and cyclo-oxygenase in hypertension. <i>Clin. Sci. (Lond.)<\/i>, <b>126<\/b>, 111\u2013121 (2014).","DOI":"10.1042\/CS20120651"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Guo Y, Kong Q, Zhang Y, Zhao J, Yu Z, He D, Huang H, Luo X. Elevated RANTES levels are associated with increased risk of cerebral atherosclerotic stenosis. <i>BMC Neurol.<\/i>, <b>23<\/b>, 39 (2023).","DOI":"10.1186\/s12883-023-03079-9"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Kong Q, Ma X, Lyu JX, Wang C, Du XY, Guan YQ. Plasma RANTES level is correlated with cardio-cerebral atherosclerosis burden in patients with ischemic cerebrovascular disease. <i>Chronic Dis. Transl. Med.<\/i>, <b>6<\/b>, 46\u201354 (2020).","DOI":"10.1016\/j.cdtm.2020.02.001"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Koper-Lenkiewicz OM, Kami\u0144ska J, Lisowska A, Milewska A, Hirnle T, Dymicka-Piekarska V. Factors associated with RANTES concentration in cardiovascular disease patients. <i>BioMed Res. Int.<\/i>, <b>2019<\/b>, 3026453 (2019).","DOI":"10.1155\/2019\/3026453"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/9\/48_b25-00490\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T04:01:44Z","timestamp":1758945704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/9\/48_b25-00490\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00490","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,23]]},"article-number":"b25-00490"}}